GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (FRA:DMN) » Definitions » Days Inventory

Diamyd Medical AB (FRA:DMN) Days Inventory : 0.00 (As of Feb. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Diamyd Medical AB Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Diamyd Medical AB's Average Total Inventories for the three months ended in Feb. 2025 was €0.00 Mil. Diamyd Medical AB's Cost of Goods Sold for the three months ended in Feb. 2025 was €0.10 Mil. Hence, Diamyd Medical AB's Days Inventory for the three months ended in Feb. 2025 was 0.00.

The historical rank and industry rank for Diamyd Medical AB's Days Inventory or its related term are showing as below:

FRA:DMN's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 177.565
* Ranked among companies with meaningful Days Inventory only.

Diamyd Medical AB's Days Inventory stayed the same from Feb. 2024 (0.00) to Feb. 2025 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Diamyd Medical AB's Inventory-to-Revenue for the three months ended in Feb. 2025 was 0.00.


Diamyd Medical AB Days Inventory Historical Data

The historical data trend for Diamyd Medical AB's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamyd Medical AB Days Inventory Chart

Diamyd Medical AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Diamyd Medical AB Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Diamyd Medical AB's Days Inventory

For the Biotechnology subindustry, Diamyd Medical AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diamyd Medical AB's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Diamyd Medical AB's Days Inventory distribution charts can be found below:

* The bar in red indicates where Diamyd Medical AB's Days Inventory falls into.


;
;

Diamyd Medical AB Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Diamyd Medical AB's Days Inventory for the fiscal year that ended in Aug. 2024 is calculated as

Days Inventory (A: Aug. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Aug. 2023 ) + Total Inventories (A: Aug. 2024 )) / count ) / Cost of Goods Sold (A: Aug. 2024 )*Days in Period
=( (0 + 0) / 1 ) / 0.324*365
=0 / 0.324*365
=0.00

Diamyd Medical AB's Days Inventory for the quarter that ended in Feb. 2025 is calculated as:

Days Inventory (Q: Feb. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Nov. 2024 ) + Total Inventories (Q: Feb. 2025 )) / count ) / Cost of Goods Sold (Q: Feb. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 0.096*365 / 4
=0 / 0.096*365 / 4
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diamyd Medical AB  (FRA:DMN) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Diamyd Medical AB's Inventory Turnover for the three months ended in Feb. 2025 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Diamyd Medical AB's Inventory to Revenue for the three months ended in Feb. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Diamyd Medical AB Days Inventory Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Diamyd Medical AB Business Description

Traded in Other Exchanges
Address
Kungsgatan 29, Stockholm, SWE, SE-111 56
Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.